{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:32:05Z","timestamp":1787610725850,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.healun.2015.05.021","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T08:10:08Z","timestamp":1434183008000},"page":"1406-1414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors"],"prefix":"10.1016","volume":"34","author":[{"given":"Gayathri","family":"Kumarasinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Nivison-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Milliken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Malouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Plit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Havryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Kotlyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy","volume":"12","author":"Evens","year":"2010","journal-title":"Current oncology reports"},{"issue":"30","key":"10.1016\/j.healun.2015.05.021_bib2","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial","year":"2005","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.healun.2015.05.021_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Leblond","year":"2001","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.healun.2015.05.021_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11864-011-0177-x","article-title":"Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations","volume":"13","author":"Jagadeesh","year":"2012","journal-title":"Current treatment options in oncology"},{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"10.1016\/j.healun.2015.05.021_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score","volume":"31","author":"Caillard","year":"2013","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.healun.2015.05.021_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","article-title":"Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience","volume":"236","author":"Jain","year":"2002","journal-title":"Annals of surgery"},{"key":"10.1016\/j.healun.2015.05.021_bib8","article-title":"EBV-related Post Transplant Lymphoproliferative Disorder (PTLD) in solid organ transplant (SOT) recipients","author":"Juan","year":"2014","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4103\/1319-2442.121270","article-title":"Ultra-early onset post-transplantation lymphoproliferative disease","volume":"24","author":"Khedmat","year":"2013","journal-title":"Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia"},{"issue":"12","key":"10.1016\/j.healun.2015.05.021_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2165\/11635690-000000000-00000","article-title":"Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens","volume":"72","author":"Murukesan","year":"2012","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03499.x","article-title":"Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy","volume":"11","author":"Nourse","year":"2011","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.healun.2015.05.021_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1743-422X-8-421","article-title":"Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients","volume":"8","author":"Baldanti","year":"2011","journal-title":"Virology journal"},{"key":"10.1016\/j.healun.2015.05.021_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fmicb.2011.00005","article-title":"Epstein-barr virus, the immune system, and associated diseases","volume":"2","author":"Chen","year":"2011","journal-title":"Frontiers in microbiology"},{"issue":"1","key":"10.1016\/j.healun.2015.05.021_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12185-012-1244-1","article-title":"Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Chen","year":"2013","journal-title":"International journal of hematology"},{"issue":"12","key":"10.1016\/j.healun.2015.05.021_bib15","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/01.pas.0000213317.59176.d2","article-title":"Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study","volume":"30","author":"Johnson","year":"2006","journal-title":"The American journal of surgical pathology"},{"key":"10.1016\/j.healun.2015.05.021_bib16","first-page":"9","article-title":"Clinicopathologic characteristics of post-transplant lymphoproliferative disorders","volume":"159","author":"Nalesnik","year":"2002","journal-title":"Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer"},{"issue":"8886-8887","key":"10.1016\/j.healun.2015.05.021_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.healun.2015.05.021_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1478-3231.2010.02303.x","article-title":"Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review","volume":"30","author":"Chak","year":"2010","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"2","key":"10.1016\/j.healun.2015.05.021_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"2","key":"10.1016\/j.healun.2015.05.021_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"American journal of hematology"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0041-1345(03)00659-6","article-title":"Current induction immunosuppression and post-heart transplant lymphoproliferative disorders","volume":"35","author":"Peraira","year":"2003","journal-title":"Transplantation proceedings"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib22","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.transproceed.2011.03.033","article-title":"Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin","volume":"43","author":"Khalpey","year":"2011","journal-title":"Transplantation proceedings"},{"issue":"3","key":"10.1016\/j.healun.2015.05.021_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12032-010-9523-2","article-title":"Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature","volume":"28","author":"Grivas","year":"2011","journal-title":"Medical oncology"},{"key":"10.1016\/j.healun.2015.05.021_bib24","doi-asserted-by":"crossref","first-page":"430209","DOI":"10.1155\/2013\/430209","article-title":"Posttransplant lymphoproliferative disease after lung transplantation","volume":"2013","author":"Neuringer","year":"2013","journal-title":"Clinical & developmental immunology"},{"issue":"3","key":"10.1016\/j.healun.2015.05.021_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Current hematologic malignancy reports"},{"issue":"2","key":"10.1016\/j.healun.2015.05.021_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"The Lancet Oncology"},{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/2040620711412417","article-title":"Therapeutic options in post-transplant lymphoproliferative disorders","volume":"2","author":"Zimmermann","year":"2011","journal-title":"Therapeutic advances in hematology"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1034\/j.1399-0012.2003.00054.x","article-title":"Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder","volume":"17","author":"Ganne","year":"2003","journal-title":"Clinical transplantation"},{"issue":"8","key":"10.1016\/j.healun.2015.05.021_bib29","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":"Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University","volume":"22","author":"Gao","year":"2003","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"3","key":"10.1016\/j.healun.2015.05.021_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.healun.2011.10.013","article-title":"Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases","volume":"31","author":"Kremer","year":"2012","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.healun.2004.04.011","article-title":"Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients","volume":"24","author":"Raj","year":"2005","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"6","key":"10.1016\/j.healun.2015.05.021_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.3880581","article-title":"Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience","volume":"15","author":"Ramalingam","year":"2002","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"4","key":"10.1016\/j.healun.2015.05.021_bib34","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1378\/chest.124.4.1242","article-title":"Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients","volume":"124","author":"Reams","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.healun.2015.05.021_bib35","doi-asserted-by":"crossref","unstructured":"Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 2005;24(11):1710-1720.","DOI":"10.1016\/j.healun.2005.03.019"},{"issue":"1 Pt 1","key":"10.1016\/j.healun.2015.05.021_bib36","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group","volume":"15","author":"Yousem","year":"1996","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"11","key":"10.1016\/j.healun.2015.05.021_bib37","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u05f3s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer research"},{"issue":"11","key":"10.1016\/j.healun.2015.05.021_bib38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u05f3s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"10.1016\/j.healun.2015.05.021_bib39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"14","key":"10.1016\/j.healun.2015.05.021_bib40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u05f3s lymphoma. The International Non-Hodgkin\u05f3s Lymphoma Prognostic Factors Project","volume":"329","year":"1993","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.healun.2015.05.021_bib41","first-page":"67","article-title":"Identification of prognostic factors in post-transplant lymphoproliferative disorders","volume":"159","author":"Choquet","year":"2002","journal-title":"Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer"},{"key":"10.1016\/j.healun.2015.05.021_bib42","first-page":"1","article-title":"Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusted with comorbidities","author":"Sevindik","year":"2015","journal-title":"Leukemia & lymphoma"},{"issue":"4","key":"10.1016\/j.healun.2015.05.021_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4103\/0973-1482.146054","article-title":"The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review","volume":"10","author":"Gao","year":"2014","journal-title":"Journal of cancer research and therapeutics"},{"issue":"1","key":"10.1016\/j.healun.2015.05.021_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00277-014-2167-0","article-title":"The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China","volume":"94","author":"Li","year":"2015","journal-title":"Annals of hematology"},{"key":"10.1016\/j.healun.2015.05.021_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.02.002","article-title":"Current preventive strategies and management of Epstein Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH questionnaire-based Cross-sectional Survey.","author":"San-Juan","year":"2015","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"4","key":"10.1016\/j.healun.2015.05.021_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"20","key":"10.1016\/j.healun.2015.05.021_bib47","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815012954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815012954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:30:22Z","timestamp":1760949022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249815012954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1053249815012954"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2015.05.021","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2015.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}